Handcuffing the culprit cancer: Immunotherapy for cold tumors with trispecific antibody ...Middle East

The recent discovery of "bispecific antibodies" has led to the development of effective immunotherapies against various cancers. Researchers have constructed a protein made up of anti-CD16, -IL-15, and -CD19 motifs, specifically designed to capture CD19-positive cancer cells and redirect them to natural killer (NK) cells. This protein also enhances the proliferation, homeostasis, activation, and survival of NK cells. This concoction has shown to induce killing of cancer cells in both cell cultures and in mouse models.

Hence then, the article about handcuffing the culprit cancer immunotherapy for cold tumors with trispecific antibody was published today ( Friday 19/02/2021 - 12:46 AM ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Handcuffing the culprit cancer: Immunotherapy for cold tumors with trispecific antibody )

Also on site :

• Walmart's 3-Piece Vintage-Inspired Makeup Bag Set Is on Sale for Just $13
• ’90s Country Music Legend Pays Tribute to Beloved Colleague After His Death 
• Trump thanks Gulf states for their ‘tremendous’ support